FDA draft guidance and health-outcomes research-Reference-Cited by-同舟云学术

FDA draft guidance and health-outcomes research

Published:2007-02 Issue:9561 Volume:369 Page:540-542
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Revicki Dennis A

Publisher

Elsevier BV

Subject

General Medicine

Reference6 articles.

1. Draft guidance for industry on patient-reported outcome measures: use in medicinal product development to support labeling claims;Fed Register,2006

2. A survey method for characterizing daily life experience: the day reconstruction methods;Kahnemann;Science,2004

3. Patient non-compliance with paper diaries;Stone;BMJ,2002

4. Symptom recording in a randomized clinical trial: paper diaries vs electronic or telephone data capture;Lauritsen;Control Clin Trials,2004

5. Responsiveness and minimal important differences for patient-reported outcomes;Revicki;Health Qual Life Outcomes,2006

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can we collect health-related quality of life information from anticoagulated atrial fibrillation participants who have recently experienced a bleed? An observational feasibility study in primary and secondary care in Wales and through a UK online forum;BMJ Open;2023-10

2. Saving time and effort: Best practice for adapting existing patient-reported outcome measures in hepatology;World Journal of Hepatology;2022-05-27

3. Patient involvement in regulation: an unvalued imperative;The Lancet;2021-06

4. Evaluating response in gastroparesis: Patient reported outcome measures and survey instruments;Gastroparesis;2021

5. A Review of Dry Eye Questionnaires: Measuring Patient-Reported Outcomes and Health-Related Quality of Life;Diagnostics;2020-08-05